RIP1 Kinase identified as promising therapeutic target in pancreatic cancer

(NYU Langone Health / NYU School of Medicine) An experimental drug may be effective against a deadly form of pancreatic cancer when used in combination with other immune-boosting therapies, according to a cover study publishing online Nov. 12 in Cancer Cell.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news